DCGI allows PNB Vesper Life Science to conduct phase-III clinical trials on PNB 001/GPP-BALACOVIN to…
PNB 001/GPP-BALACOVIN proving to be a major breakthrough in COVID-19 treatment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
PNB Vesper
PNB Vesper completes Phase 2 of clinical trials of GPP-Baladol on COVID-19 patients
Clinical trial report to be submitted to Drug Controller General of India on February 22, 2021
PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients
A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support
PNB Vesper: Betting big on research
Kochi-based PNB Vesper’s semi-virtual web of researchers, universities, and CROs across continents has some promising leads in the…